Literature DB >> 10950944

Human bone marrow stromal cell: coexpression of markers specific for multiple mesenchymal cell lineages.

B Seshi1, S Kumar, D Sellers.   

Abstract

The role of hematopoietic stem cells in blood cell development is reasonably understood, whereas the identity and the function of bone marrow stromal cells are much less clear. Using stromal cells in bone marrow cultures of the Dexter type, a favorite medium for the study of hematopoiesis, we show that stromal cells actually represent a unique cell type. Conventional wisdom has held that stromal cells in Dexter cultures comprise a mixture of macrophages, hematopoietic cells, adipocytes, osteoblasts, fibroblasts, muscle cells, and endothelial cells. Our findings demonstrate that Dexter cultures consist of three cell types: macrophages ( approximately 35%), hematopoietic cells ( approximately 5%), and nonhematopoietic cells ( approximately 60%). We have purified the nonhematopoietic cells free of macrophages and hematopoietic cells to produce compelling evidence that they in fact represent a single cell type (multidifferentiated mesenchymal progenitor cell, MPC) which coexpresses genes specific for various mesenchymal cell lineages including adipocytes, osteoblasts, fibroblasts, and muscle cells. We further show that these multi- or pluridifferentiated MPCs are capable of supporting hematopoiesis by demonstrating the expression of several hematopoietic growth factors and extracellular matrix receptors including G-CSF, SCF, VCAM-1, ICAM-1, and ALCAM. Since the MPCs can be easily purified to near homogeneity (95%), they can be of value in enhancing engraftment of hematopoietic stem cells. Also, this new understanding of bone marrow stromal cells as "one cell with many different faces" promises to advance our knowledge of regulatory cellular interactions within bone marrow. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10950944     DOI: 10.1006/bcmd.2000.0301

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  19 in total

Review 1.  A strategy for identifying osteoporosis risk genes.

Authors:  David Rowe; Alexander Lichtler
Journal:  Endocrine       Date:  2002-02       Impact factor: 3.633

2.  Development and performance analysis of PCL/silica nanocomposites for bone regeneration.

Authors:  Luigi Calandrelli; Marco Annunziata; Fulvio Della Ragione; Paola Laurienzo; Mario Malinconico; Adriana Oliva
Journal:  J Mater Sci Mater Med       Date:  2010-10-07       Impact factor: 3.896

3.  Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1.

Authors:  Venkata Lokesh Battula; Sabrina Treml; Petra M Bareiss; Friederike Gieseke; Helene Roelofs; Peter de Zwart; Ingo Müller; Bernhard Schewe; Thomas Skutella; Willem E Fibbe; Lothar Kanz; Hans-Jörg Bühring
Journal:  Haematologica       Date:  2008-12-09       Impact factor: 9.941

4.  Clinical implications of activated leukocyte cell adhesion molecule expression in breast cancer.

Authors:  Daxun Piao; Tao Jiang; Gavin Liu; Baosheng Wang; Jin Xu; Anlong Zhu
Journal:  Mol Biol Rep       Date:  2011-06-14       Impact factor: 2.316

5.  The effect of a polyurethane-based reverse thermal gel on bone marrow stromal cell transplant survival and spinal cord repair.

Authors:  Gaby J Ritfeld; Britta M Rauck; Tabitha L Novosat; Daewon Park; Pavan Patel; Raymund A C Roos; Yadong Wang; Martin Oudega
Journal:  Biomaterials       Date:  2013-12-09       Impact factor: 12.479

6.  Regulation of human hematopoietic stem cell self-renewal by the microenvironment's control of retinoic acid signaling.

Authors:  Gabriel Ghiaur; Srinivasan Yegnasubramanian; Brandy Perkins; Jessica L Gucwa; Jonathan M Gerber; Richard J Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

Review 7.  Use of genetically modified mesenchymal stem cells to treat neurodegenerative diseases.

Authors:  Robert D Wyse; Gary L Dunbar; Julien Rossignol
Journal:  Int J Mol Sci       Date:  2014-01-23       Impact factor: 5.923

8.  Stem cells ameliorate EAE via an indoleamine 2,3-dioxygenase (IDO) mechanism.

Authors:  Mariola Matysiak; Mariusz Stasiołek; Wojciech Orłowski; Anna Jurewicz; Szymon Janczar; Cedric S Raine; Krzysztof Selmaj
Journal:  J Neuroimmunol       Date:  2008-01       Impact factor: 3.478

9.  Cytoplasmic overexpression of ALCAM is prognostic of disease progression in breast cancer.

Authors:  M Burkhardt; E Mayordomo; K-J Winzer; F Fritzsche; T Gansukh; S Pahl; W Weichert; C Denkert; H Guski; M Dietel; G Kristiansen
Journal:  J Clin Pathol       Date:  2006-02-16       Impact factor: 3.411

10.  Multipotent properties of myofibroblast cells derived from human placenta.

Authors:  Zuzana Strakova; Mark Livak; Monika Krezalek; Ivanna Ihnatovych
Journal:  Cell Tissue Res       Date:  2008-04-10       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.